FDA issues final guidance on oversight of clinical studies

08/12/2013 | OutSourcing-Pharma.com

The FDA has released a final guidance governing clinical trial oversight, urging drug and medical-device sponsors to utilize more remote and targeted risk-based monitoring rather than relying solely on on-site methods. The guidance provides various risk-based monitoring strategies and clarifies that the sponsor can transfer monitoring responsibilities to contract research organizations, but it "should evaluate CRO compliance with regulatory requirements and contractual obligations in an ongoing manner."

View Full Article in:

OutSourcing-Pharma.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY